Modifi Bio
Industry
- Pharmaceuticals
- Biotechnology
- Gene Therapy, Cell Therapy
See more in Biomedtracker
Latest on Modifi Bio
In Vivo
• By Maureen Riordan and Deanna Kamienski
Biopharma merger and acquisition value for the fourth quarter of 2024 reached $9.4bn from 34 transactions, 15 of which had disclosed values. At the top was H. Lundbeck’s $2.6bn purchase of publicly tr
Scrip
• By Alaric DeArment
Merck & Co., Inc. could spend more than $1.3bn to acquire Modifi Biosciences, but the initial cost of the deal is a much more modest investment in a company with a suite of preclinical assets desi